Comments on Proposed Rule Implementing the Global Benchmark for Efficient Drug Pricing (GLOBE) Model

The commenters support the GLOBE Model’s goal of reducing Medicare Part B drug costs through international reference pricing and recommends that CMS use a narrower basket of economically comparable reference countries and define the benchmark using the median of country-level prices rather than the proposed approach.